phase trial piritrexim capsul prolong low-dos oral administr treatment advanc malign phase trial piritrexim use prolong low-dos oral schedul number differ regimen daili day day drug therapi continu dose daili day consecut week week rest dose escal dose frequenc day day time day number day administr patient advanc cancer studi twenty-four cours assess myelosuppress dose-limit toxic effect other toxic effect stomat nausea vomit anorexia diarrhea skin rash fatigu elev liver transaminas level antitumor activ patient melanoma bladder cancer diseas stabil sarcoma pheochromocytoma recommend dose schedul phase II clinic trial mg time day day consecut week week drug therapi 